Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Tilray Brands Inc (TLRY) vs Global X Uranium ETF (URA) Price & Performance

Tilray Brands IncTrade
Global X Uranium ETFTrade

Price performance (Past 24H)

Key statistics

Tilray Brands Inc vs Global X Uranium ETF — how do they compare? Tilray Brands Inc trades at $4.25 (market cap $524.07M), while Global X Uranium ETF trades at $40.37. The key difference: Global X Uranium ETF is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals.

TLRYURA
Market Cap
$524.07M
Sector
HealthCommodities - Metals/Agriculture
52-Week High
$21.00$61.81
52-Week Low
$4.23$36.45
Enterprise Value
$621.22M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Tilray Brands Inc

TLRY trades at $4.23, down 1.63% on the day, with a bearish technical signal and negative earnings trends. The company reported a net loss of $2.19 billion in 2025 despite revenue growth to $821.31 million, reflecting deep profitability challenges. Analysts show cautious sentiment with 65% hold ratings, while recent news highlights expansion in medical cannabis and beverage segments amid ongoing regulatory uncertainty.

The outlook remains challenged by persistent losses and high debt-to-asset ratio of 12.25, though low P/S and P/B ratios suggest undervaluation. Key risks include profitability execution and federal cannabis policy shifts, while potential catalysts lie in international expansion and cost management improvements.

Global X Uranium ETF

URA trades at $38.64, down 0.28% on the day, with technical indicators showing a bearish trend from moving averages but oversold RSI signals. The ETF holds $6.29 billion in assets and benefits from strong narratives around AI-driven power demand and nuclear energy expansion, though key financial ratios are not publicly detailed for the fund itself. Recent news highlights uranium's role in meeting data center electricity needs.

Outlook is supported by structural demand trends, but high expense ratios and competition from pure-play uranium funds pose risks. The fund's performance hinges on uranium price movements and policy developments, with current technical weakness suggesting caution in the near term.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY

About Global X Uranium ETF

URA provides broad exposure to the global uranium industry and nuclear energy sector. Unlike pure-play mining funds, it includes companies involved in nuclear component production and infrastructure, with top 2026 holdings such as Cameco, Oklo, and Uranium Energy Corp.

Read more on URA